Tg Therapeutics TGTX
NASDAQ TGTX
$53.62 -2.16 (-3.87%)
As of: Oct 1, 2026 · 3:59 PM EDT

Tg Therapeutics (TGTX) Operating Interest Expenses (2020 - 2023)

Updated

Tg Therapeutics (TGTX) recorded Operating Interest Expenses of $2 million in Q1 2023, down 73.0% from $7.4 million a year earlier.

Analysis

Tg Therapeutics (TGTX) Operating Interest Expenses (2020 - 2023) Analysis & Trends

For FY2022, Tg Therapeutics reported Operating Interest Expenses of $7.4 million, unchanged from FY2021.

  • Annual Operating Interest Expenses has a three-year compound annual growth rate of 38.3% (FY2019 to FY2022).
  • Across earlier years, Operating Interest Expenses came in at $7.4 million in FY2021 (+164.3%), $2.8 million in FY2020 (unchanged) and $2.8 million in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Interest Exp. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Tg Therapeutics 8.54 Bn 7.93 Bn 199.14 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 2.00 Mn
Mar 31, 2022 7.40 Mn
Dec 31, 2021 4.60 Mn
Mar 31, 2021 2.80 Mn
Mar 31, 2020 2.80 Mn
API Access

Tg Therapeutics Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-interest-expenses&ticker=TGTX&period=max&api_key=YOUR_API_KEY